176 related articles for article (PubMed ID: 14662972)
1. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients.
Robinson P; Carzino R; Armstrong D; Olinsky A
J Clin Microbiol; 2003 Dec; 41(12):5741. PubMed ID: 14662972
[TBL] [Abstract][Full Text] [Related]
2. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
[TBL] [Abstract][Full Text] [Related]
3. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.
McCallum SJ; Corkill J; Gallagher M; Ledson MJ; Hart CA; Walshaw MJ
Lancet; 2001 Aug; 358(9281):558-60. PubMed ID: 11520530
[TBL] [Abstract][Full Text] [Related]
4. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
[TBL] [Abstract][Full Text] [Related]
5. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.
Jones AM; Govan JR; Doherty CJ; Dodd ME; Isalska BJ; Stanbridge TN; Webb AK
Lancet; 2001 Aug; 358(9281):557-8. PubMed ID: 11520529
[TBL] [Abstract][Full Text] [Related]
6. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.
McCallum SJ; Gallagher MJ; Corkill JE; Hart CA; Ledson MJ; Walshaw MJ
Thorax; 2002 Jun; 57(6):559-60. PubMed ID: 12037234
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
8. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
Kelly NM; Fitzgerald MX; Tempany E; O'Boyle C; Falkiner FR; Keane CT
Lancet; 1982 Sep; 2(8300):688-90. PubMed ID: 6126629
[TBL] [Abstract][Full Text] [Related]
9. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
10. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
Agarwal G; Kapil A; Kabra SK; Das BK
Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
[No Abstract] [Full Text] [Related]
11. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.
Festini F; Taccetti G; Galici V; Neri S; Bisogni S; Ciofi D; Braggion C
Am J Infect Control; 2010 Apr; 38(3):244-5. PubMed ID: 20129701
[TBL] [Abstract][Full Text] [Related]
12. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.
Armstrong D; Bell S; Robinson M; Bye P; Rose B; Harbour C; Lee C; Service H; Nissen M; Syrmis M; Wainwright C
J Clin Microbiol; 2003 May; 41(5):2266-7. PubMed ID: 12734299
[No Abstract] [Full Text] [Related]
13. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
14. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].
Menetrey Q; Dupont C; Chiron R; Marchandin H
Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
Moore JE; Mastoridis P
J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
[TBL] [Abstract][Full Text] [Related]
16. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring?
Taylor RF; Dalla Costa L; Kaufmann ME; Pitt TL; Hodson ME
J Hosp Infect; 1992 Jul; 21(3):199-204. PubMed ID: 1379274
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.
Wolz C; Kiosz G; Ogle JW; Vasil ML; Schaad U; Botzenhart K; Döring G
Epidemiol Infect; 1989 Apr; 102(2):205-14. PubMed ID: 2495226
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
[TBL] [Abstract][Full Text] [Related]
20. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
